These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 17093363)

  • 21. Postoperative nausea and vomiting.
    Kreis ME
    Auton Neurosci; 2006 Oct; 129(1-2):86-91. PubMed ID: 16942921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis of the safety of 5-HT3 antagonists with dexamethasone or droperidol for prevention of PONV.
    Leslie JB; Gan TJ
    Ann Pharmacother; 2006 May; 40(5):856-72. PubMed ID: 16670360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implications.
    Bernard S; Neville KA; Nguyen AT; Flockhart DA
    Oncologist; 2006 Feb; 11(2):126-35. PubMed ID: 16476833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haloperidol versus ondansetron for prophylaxis of postoperative nausea and vomiting.
    Rosow CE; Haspel KL; Smith SE; Grecu L; Bittner EA
    Anesth Analg; 2008 May; 106(5):1407-9, table of contents. PubMed ID: 18420852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nausea and vomiting after office-based anesthesia.
    Kolodzie K; Apfel CC
    Curr Opin Anaesthesiol; 2009 Aug; 22(4):532-8. PubMed ID: 19512914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of radiation-induced nausea and vomiting.
    Abdelsayed GG
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):34-6. PubMed ID: 17379085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Physiopathology, risk factors and therapy. Postoperative Nausea and vomiting (PONV)].
    Wurglics M; Spiegl F
    Pharm Unserer Zeit; 2007; 36(5):368-72. PubMed ID: 17722164
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevention of postoperative nausea and vomiting.
    Wilhelm SM; Dehoorne-Smith ML; Kale-Pradhan PB
    Ann Pharmacother; 2007 Jan; 41(1):68-78. PubMed ID: 17200430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on the management of postoperative nausea and vomiting and postdischarge nausea and vomiting in ambulatory surgery.
    Le TP; Gan TJ
    Anesthesiol Clin; 2010 Jun; 28(2):225-49. PubMed ID: 20488392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients.
    Tremblay PB; Kaiser R; Sezer O; Rosler N; Schelenz C; Possinger K; Roots I; Brockmoller J
    J Clin Oncol; 2003 Jun; 21(11):2147-55. PubMed ID: 12775740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Algorithms for the prevention of postoperative nausea and vomiting: an efficacy and efficiency simulation.
    Kranke P; Eberhart LH; Gan TJ; Roewer N; Tramèr MR
    Eur J Anaesthesiol; 2007 Oct; 24(10):856-67. PubMed ID: 17608963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of chemotherapy-induced nausea and vomiting with 5-hydroxytryptamine type 3 receptor antagonists].
    Abenhardt W; Bosse D; Böning L; Bojko P; Hitz H; Völkl S; Fromm M; Mittermüller J; Göldel N; Schick HD; Dietzfelbinger H; Hinke A
    Dtsch Med Wochenschr; 2006 Dec; 131(48):2707-12. PubMed ID: 17123235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How much does pharmacologic prophylaxis reduce postoperative vomiting in children? Calculation of prophylaxis effectiveness and expected incidence of vomiting under treatment using Bayesian meta-analysis.
    Engelman E; Salengros JC; Barvais L
    Anesthesiology; 2008 Dec; 109(6):1023-35. PubMed ID: 19034099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron.
    Bell GC; Caudle KE; Whirl-Carrillo M; Gordon RJ; Hikino K; Prows CA; Gaedigk A; Agundez J; Sadhasivam S; Klein TE; Schwab M
    Clin Pharmacol Ther; 2017 Aug; 102(2):213-218. PubMed ID: 28002639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-emetic therapy in cancer chemotherapy: current status.
    Herrstedt J; Dombernowsky P
    Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):143-50. PubMed ID: 17697032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylaxis versus treatment: is there a better way to manage radiotherapy-induced nausea and vomiting?
    Horiot JC
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1018-25. PubMed ID: 15519770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiemetic prophylaxis: pharmacology and therapeutics.
    Norred CL
    AANA J; 2003 Apr; 71(2):133-40. PubMed ID: 12776642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevention and treatment of postoperative nausea and vomiting in children. An evidence-based approach].
    Tramèr MR
    Ann Fr Anesth Reanim; 2007 Jun; 26(6):529-34. PubMed ID: 17521856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of antiemetic efficacy of 5-HT3 receptor antagonists in orthopedics cancer patients receiving high-dose chemotherapy].
    Takenaka M; Okamoto Y; Ikeda K; Hashimoto R; Ueda T; Kurokawa N; Takagi T; Uejima E
    Gan To Kagaku Ryoho; 2007 Mar; 34(3):403-7. PubMed ID: 17353632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The addition of dexamethasone to dolasetron or haloperidol for treatment of established postoperative nausea and vomiting.
    Rüsch D; Arndt C; Martin H; Kranke P
    Anaesthesia; 2007 Aug; 62(8):810-7. PubMed ID: 17635430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.